1. Home
  2. CBAN vs CRDF Comparison

CBAN vs CRDF Comparison

Compare CBAN & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Colony Bankcorp Inc.

CBAN

Colony Bankcorp Inc.

HOLD

Current Price

$18.05

Market Cap

282.0M

Sector

Finance

ML Signal

HOLD

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

HOLD

Current Price

$3.20

Market Cap

142.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBAN
CRDF
Founded
1975
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
282.0M
142.1M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
CBAN
CRDF
Price
$18.05
$3.20
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.63
AVG Volume (30 Days)
93.4K
1.0M
Earning Date
01-21-2026
11-06-2025
Dividend Yield
2.55%
N/A
EPS Growth
26.78
N/A
EPS
1.59
N/A
Revenue
$122,550,000.00
$501,000.00
Revenue This Year
$20.97
N/A
Revenue Next Year
$25.65
N/A
P/E Ratio
$11.36
N/A
Revenue Growth
12.48
N/A
52 Week Low
$13.99
$1.90
52 Week High
$18.80
$4.99

Technical Indicators

Market Signals
Indicator
CBAN
CRDF
Relative Strength Index (RSI) 60.63 80.94
Support Level $18.18 $2.32
Resistance Level $18.80 $2.95
Average True Range (ATR) 0.37 0.17
MACD -0.03 0.08
Stochastic Oscillator 59.44 94.78

Price Performance

Historical Comparison
CBAN
CRDF

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

Share on Social Networks: